Safety and Efficacy of Topical Cream for Post-inflammatory Hyperpigmentation Skin Among Malaysians
Healthy
About this trial
This is an interventional other trial for Healthy focused on measuring Aesthetic, Cosmetic, Post-inflammatory hyperpigmentation (PIH)
Eligibility Criteria
Inclusion Criteria: Malaysia citizen Healthy adult, aged between 18 to 40 years old. Participants who have post-inflammatory hyperpigmentation on skin Exclusion Criteria: Participants with skin disorders such as skin infection or skin inflammation. Participants who have undergone any skin and cosmetic treatments such as dermal fillers, botox, laser, chemical peels within the last 3 months. Participant who is taking isotretinoin for the past 6 or 12 months and immunocompromised patients. Pregnant, breastfeeding women or planned for pregnancy during the study period.
Sites / Locations
- Ungku Shahrin Medical Aesthetic Research & Innovation (USMARI) CentreRecruiting
Arms of the Study
Arm 1
Other
Topical cream for PIH
The topical cream contain combination of niacinamide, arbutin, Scutellaria Baicalensis Root Extract, Centella Asiatica Extract and Camellia Sinensis Leaf Extract.